Skip to Content

375/20 (Vimovo esomeprazole 20 mg / naproxen 375 mg)

Generic Name: esomeprazole/naproxen

Pill with imprint 375/20 is Yellow, Elliptical / Oval and has been identified as Vimovo esomeprazole 20 mg / naproxen 375 mg. It is supplied by AstraZeneca Pharmaceuticals.

Vimovo is used in the treatment of osteoarthritis; ankylosing spondylitis; nsaid-induced ulcer prophylaxis; rheumatoid arthritis and belongs to the drug class Nonsteroidal anti-inflammatory drugs. Prior to 30 weeks gestation: Risk cannot be ruled out during pregnancy. Starting at 30 weeks gestation: There is positive evidence of human fetal risk during pregnancy. Vimovo esomeprazole 20 mg / naproxen 375 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for 375/20

Vimovo

Generic Name:
esomeprazole/naproxen
Imprint:
375/20
Strength:
esomeprazole 20 mg / naproxen 375 mg
Color:
Yellow
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Nonsteroidal anti-inflammatory drugs
Pregnancy Category:
C - Risk cannot be ruled out - prior to 30 weeks gestation
D - Positive evidence of risk - starting at 30 weeks gestation
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
AstraZeneca Pharmaceuticals
Inactive Ingredients:
carnauba wax
silicon dioxide
croscarmellose sodium
ferric oxide yellow
glyceryl monostearate
hypromelloses
magnesium stearate
methacrylic acid
methylparaben
polysorbate 80
polyethylene glycol
povidone
propylparaben
titanium dioxide
triethyl citrate
ferrosoferric oxide
polydextrose
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide